Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 292

1.

Health impact of electronic cigarettes and heated tobacco systems.

Polosa R, Farsalinos K, Prisco D.

Intern Emerg Med. 2019 Aug 14. doi: 10.1007/s11739-019-02167-4. [Epub ahead of print] No abstract available.

PMID:
31414334
2.

Efficacy of smoking cessation with varenicline plus counselling for e-cigarettes users (VAREVAPE): A protocol for a randomized controlled trial.

Caponnetto P, Maglia M, Polosa R.

Contemp Clin Trials Commun. 2019 Jul 19;15:100412. doi: 10.1016/j.conctc.2019.100412. eCollection 2019 Sep.

3.

The effect of e-cigarette aerosol emissions on respiratory health: a narrative review.

Polosa R, O'Leary R, Tashkin D, Emma R, Caruso M.

Expert Rev Respir Med. 2019 Aug 2:1-17. doi: 10.1080/17476348.2019.1649146. [Epub ahead of print]

PMID:
31375047
4.

An evaluation of mepolizumab for the treatment of severe asthma.

Morjaria JB, Emma R, Fuochi V, Polosa R, Caruso M.

Expert Opin Biol Ther. 2019 Jun;19(6):491-500. doi: 10.1080/14712598.2019.1610382. Epub 2019 May 7.

PMID:
31009582
5.

Improving neurocognitive functioning in schizophrenia by addition of cognitive remediation therapy to a standard treatment of metacognitive training.

Caponnetto P, Maglia M, Auditore R, Bocchieri M, Caruso A, DiPiazza J, Polosa R.

Ment Illn. 2018 Dec 20;10(2):7812. doi: 10.4081/mi.2018.7812. eCollection 2018 Nov 6.

6.

Mepolizumab in the management of severe eosinophilic asthma in adults: current evidence and practical experience.

Emma R, Morjaria JB, Fuochi V, Polosa R, Caruso M.

Ther Adv Respir Dis. 2018 Jan-Dec;12:1753466618808490. doi: 10.1177/1753466618808490. Review.

7.

Commentary: Inflammatory and Oxidative Responses Induced by Exposure to Commonly Used e-Cigarette Flavoring Chemicals and Flavored e-Liquids without Nicotine.

Caruso M, Li Volti G, Furneri PM, Fuochi V, Emma R, Polosa R.

Front Physiol. 2018 Sep 13;9:1240. doi: 10.3389/fphys.2018.01240. eCollection 2018. No abstract available.

8.

Health effects in COPD smokers who switch to electronic cigarettes: a retrospective-prospective 3-year follow-up.

Polosa R, Morjaria JB, Prosperini U, Russo C, Pennisi A, Puleo R, Caruso M, Caponnetto P.

Int J Chron Obstruct Pulmon Dis. 2018 Aug 22;13:2533-2542. doi: 10.2147/COPD.S161138. eCollection 2018.

9.

Electronic cigarette vapour enhances pneumococcal adherence to airway epithelial cells under abnormal conditions of exposure.

Caruso M, Emma R, Fuochi V, Furneri PM, Polosa R.

Eur Respir J. 2018 Sep 6;52(3). pii: 1800915. doi: 10.1183/13993003.00915-2018. Print 2018 Sep. No abstract available.

PMID:
30190260
10.

Carbon monoxide levels after inhalation from new generation heated tobacco products.

Caponnetto P, Maglia M, Prosperini G, Busà B, Polosa R.

Respir Res. 2018 Aug 31;19(1):164. doi: 10.1186/s12931-018-0867-z.

11.

Basophil biomarkers as useful predictors for sublingual immunotherapy in allergic rhinitis.

Caruso M, Cibella F, Emma R, Campagna D, Tringali G, Amaradio MD, Polosa R.

Int Immunopharmacol. 2018 Jul;60:50-58. doi: 10.1016/j.intimp.2018.04.034. Epub 2018 Apr 25.

PMID:
29702283
12.

Frequency of Use and Smoking Status of U.S. Adolescent E-Cigarette Users in 2015.

Farsalinos K, Tomaselli V, Polosa R.

Am J Prev Med. 2018 Jun;54(6):814-820. doi: 10.1016/j.amepre.2018.03.003. Epub 2018 Apr 7.

PMID:
29631871
13.

Treatment of Allergic Rhinitis as a Strategy for Preventing Asthma.

Morjaria JB, Caruso M, Emma R, Russo C, Polosa R.

Curr Allergy Asthma Rep. 2018 Mar 24;18(4):23. doi: 10.1007/s11882-018-0781-y. Review.

PMID:
29574527
14.

Lack of Substantial Post-Cessation Weight Increase in Electronic Cigarettes Users.

Russo C, Cibella F, Mondati E, Caponnetto P, Frazzetto E, Caruso M, Caci G, Polosa R.

Int J Environ Res Public Health. 2018 Mar 23;15(4). pii: E581. doi: 10.3390/ijerph15040581.

15.

E-Cigarette and COPD: Unreliable Conclusion About Health Risks.

Cummings KM, Polosa R.

J Gen Intern Med. 2018 Jun;33(6):784-785. doi: 10.1007/s11606-018-4396-8. No abstract available.

16.

Assessment of E-cigarette impact on smokers: The importance of experimental conditions relevant to human consumption.

Li Volti G, Polosa R, Caruso M.

Proc Natl Acad Sci U S A. 2018 Apr 3;115(14):E3073-E3074. doi: 10.1073/pnas.1801967115. Epub 2018 Mar 13. No abstract available.

17.

Training pharmacists in the stage-of-change model of smoking cessation and motivational interviewing: A randomized controlled trial.

Caponnetto P, DiPiazza J, Aiello MR, Polosa R.

Health Psychol Open. 2017 Oct 28;4(2):2055102917736429. doi: 10.1177/2055102917736429. eCollection 2017 Jul-Dec.

18.

E-cigarettes unlikely to raise significant health concerns in airways disease.

Polosa R.

Respirology. 2018 Apr;23(4):435-436. doi: 10.1111/resp.13256. Epub 2018 Jan 9. No abstract available.

PMID:
29316603
19.

Biologic agents for severe asthma patients: clinical perspectives and implications.

Caruso M, Morjaria J, Emma R, Amaradio MD, Polosa R.

Intern Emerg Med. 2018 Mar;13(2):155-176. doi: 10.1007/s11739-017-1773-y. Epub 2017 Dec 14. Review.

PMID:
29238905
20.

Are we addressing relevant determinants of smoking cessation?

Caponnetto P, Polosa R.

Eur Respir J. 2017 Nov 22;50(5). pii: 1701615. doi: 10.1183/13993003.01615-2017. Print 2017 Nov. No abstract available.

21.

Health impact of E-cigarettes: a prospective 3.5-year study of regular daily users who have never smoked.

Polosa R, Cibella F, Caponnetto P, Maglia M, Prosperini U, Russo C, Tashkin D.

Sci Rep. 2017 Nov 17;7(1):13825. doi: 10.1038/s41598-017-14043-2.

22.

E-cigarettes in patients with COPD: current perspectives.

Morjaria JB, Mondati E, Polosa R.

Int J Chron Obstruct Pulmon Dis. 2017 Nov 1;12:3203-3210. doi: 10.2147/COPD.S135323. eCollection 2017. Review.

23.

Perplexing Conclusions Concerning Heat-Not-Burn Tobacco Cigarettes.

Caruso M, Polosa R.

JAMA Intern Med. 2017 Nov 1;177(11):1699. doi: 10.1001/jamainternmed.2017.5843. No abstract available.

PMID:
29114793
24.

Letter to the Editor: Pulmonary toxicity of electronic cigarettes: more doubts than certainties.

Caruso M, Mendelsohn CP, Polosa R.

Am J Physiol Lung Cell Mol Physiol. 2017 Nov 1;313(5):L964-L965. doi: 10.1152/ajplung.00402.2017. No abstract available.

25.

A review article on biosimilar infliximab SB2 in the treatment of rheumatoid arthritis.

Bellinvia S, Ashraf M, Polosa R, Edwards C.

Immunotherapy. 2017 Nov;9(14):1133-1142. doi: 10.2217/imt-2017-0068. Epub 2017 Sep 18. Review.

PMID:
29067885
26.

Scientific and ethical obligations to publish tobacco industry-funded research on nicotine delivery systems of reduced risk.

Polosa R, Crawley FP.

Toxicology. 2017 Sep 1;390:61-62. doi: 10.1016/j.tox.2017.09.003. Epub 2017 Sep 4. No abstract available.

PMID:
28882573
27.

A critique of the US Surgeon General's conclusions regarding e-cigarette use among youth and young adults in the United States of America.

Polosa R, Russell C, Nitzkin J, Farsalinos KE.

Harm Reduct J. 2017 Sep 6;14(1):61. doi: 10.1186/s12954-017-0187-5. Review.

28.

Emerging potential for bisphosphonates in the treatment of axial spondyloarthritis.

Sambataro G, Sambataro D, Polosa R.

Ther Adv Chronic Dis. 2017 Jun;8(6-7):97-99. doi: 10.1177/2040622317702363. Epub 2017 May 10. No abstract available.

29.

Erratum to: Analysis of E-cigarette use in the 2014 Eurobarometer survey: calling out deficiencies in epidemiology methods.

Polosa R, Caponnetto P, Niaura R, Abrams D.

Intern Emerg Med. 2017 Sep;12(6):907. doi: 10.1007/s11739-017-1685-x. No abstract available.

30.

Analysis of E-cigarette use in the 2014 Eurobarometer survey: calling out deficiencies in epidemiology methods.

Polosa R, Caponnetto P, Niaura R, Abrams D.

Intern Emerg Med. 2017 Sep;12(6):733-735. doi: 10.1007/s11739-017-1667-z. Epub 2017 May 5. No abstract available. Erratum in: Intern Emerg Med. 2017 Sep;12 (6):907.

31.

Is there any role for thoracic ultrasound for interstitial lung disease underlying rheumatologic conditions? Reply.

Sambataro D, Sambataro G, Dal Bosco Y, Campagna D, Polosa R.

Intern Emerg Med. 2017 Sep;12(6):905-906. doi: 10.1007/s11739-017-1669-x. Epub 2017 Apr 27. No abstract available.

PMID:
28451992
32.

Necrotizing Panniculitis as an Uncommon Manifestation of Acute Pancreatitis.

Bruno CM, Pricoco GS, Bellinvia S, Amaradio MD, Cantone D, Polosa R.

Eur J Case Rep Intern Med. 2017 Apr 27;4(3):000540. doi: 10.12890/2017_000540. eCollection 2017.

33.

A Risk Assessment Matrix for Public Health Principles: The Case for E-Cigarettes.

Saitta D, Chowdhury A, Ferro GA, Nalis FG, Polosa R.

Int J Environ Res Public Health. 2017 Mar 31;14(4). pii: E363. doi: 10.3390/ijerph14040363.

34.

Impact of Different e-Cigarette Generation and Models on Cognitive Performances, Craving and Gesture: A Randomized Cross-Over Trial (CogEcig).

Caponnetto P, Maglia M, Cannella MC, Inguscio L, Buonocore M, Scoglio C, Polosa R, Vinci V.

Front Psychol. 2017 Mar 9;8:127. doi: 10.3389/fpsyg.2017.00127. eCollection 2017.

35.

Is there any role for thoracic ultrasound for interstitial lung disease underlying rheumatologic conditions?

Sambataro D, Sambataro G, Dal Bosco Y, Campagna D, Polosa R.

Intern Emerg Med. 2017 Apr;12(3):283-285. doi: 10.1007/s11739-017-1642-8. Epub 2017 Mar 4. Review. No abstract available.

PMID:
28260220
36.

Endothelial progenitor cell release is usually considered a beneficial effect: Problems in interpreting the acute effects of e-cigarette use.

Farsalinos KE, Polosa R.

Atherosclerosis. 2017 Mar;258:162-163. doi: 10.1016/j.atherosclerosis.2016.12.016. Epub 2016 Dec 21. No abstract available.

PMID:
28034508
37.

The Health Effects of Electronic Cigarettes.

Polosa R, Caponnetto P.

N Engl J Med. 2016 Dec 29;375(26):2608. No abstract available.

PMID:
28032962
38.

Evidence for harm reduction in COPD smokers who switch to electronic cigarettes.

Polosa R, Morjaria JB, Caponnetto P, Prosperini U, Russo C, Pennisi A, Bruno CM.

Respir Res. 2016 Dec 16;17(1):166.

39.

Blood Pressure Control in Smokers with Arterial Hypertension Who Switched to Electronic Cigarettes.

Polosa R, Morjaria JB, Caponnetto P, Battaglia E, Russo C, Ciampi C, Adams G, Bruno CM.

Int J Environ Res Public Health. 2016 Nov 11;13(11). pii: E1123.

40.

E-cigarettes and smoking cessation: a critique of a New England Journal Medicine-commissioned case study.

Polosa R, Caponnetto P.

Intern Emerg Med. 2017 Feb;12(1):129-131. doi: 10.1007/s11739-016-1537-0. Epub 2016 Sep 24. No abstract available.

41.

Present and future of biologic drugs in primary Sjögren's syndrome.

Sambataro D, Sambataro G, Dal Bosco Y, Polosa R.

Expert Opin Biol Ther. 2017 Jan;17(1):63-75. Epub 2016 Sep 20. Review.

PMID:
27616561
42.

Lung function and respiratory symptoms in a randomized smoking cessation trial of electronic cigarettes.

Cibella F, Campagna D, Caponnetto P, Amaradio MD, Caruso M, Russo C, Cockcroft DW, Polosa R.

Clin Sci (Lond). 2016 Nov 1;130(21):1929-37. doi: 10.1042/CS20160268. Epub 2016 Aug 19.

PMID:
27543458
43.

Smoking history can influence the epigenetic and gene expression profile.

Emma R, Caruso M, Polosa R.

Am J Physiol Lung Cell Mol Physiol. 2016 Aug 1;311(2):L525. doi: 10.1152/ajplung.00285.2016. No abstract available.

44.

Changes in breathomics from a 1-year randomized smoking cessation trial of electronic cigarettes.

Campagna D, Cibella F, Caponnetto P, Amaradio MD, Caruso M, Morjaria JB, Malerba M, Polosa R.

Eur J Clin Invest. 2016 Aug;46(8):698-706. doi: 10.1111/eci.12651. Epub 2016 Jul 8.

PMID:
27322745
45.

Respiratory infections and pneumonia: potential benefits of switching from smoking to vaping.

Campagna D, Amaradio MD, Sands MF, Polosa R.

Pneumonia (Nathan). 2016 Apr 12;8:4. doi: 10.1186/s41479-016-0001-2. eCollection 2016.

46.

E-cigarettes are less harmful than smoking.

Nutt DJ, Phillips LD, Balfour D, Curran HV, Dockrell M, Foulds J, Fagerstrom K, Letlape K, Polosa R, Ramsey J, Sweanor D.

Lancet. 2016 Mar 19;387(10024):1160-2. doi: 10.1016/S0140-6736(15)00253-6. No abstract available.

PMID:
27025332
47.

Persisting long term benefits of smoking abstinence and reduction in asthmatic smokers who have switched to electronic cigarettes.

Polosa R, Morjaria JB, Caponnetto P, Caruso M, Campagna D, Amaradio MD, Ciampi G, Russo C, Fisichella A.

Discov Med. 2016 Feb;21(114):99-108.

48.

Comments on Scheffler et al. Cytotoxic Evaluation of E-Liquid Aerosol using Different Lung Derived Cell Models. Int. J. Environ. Res. Public Health, 2015, 12, 12466-12474.

Polosa R, Caruso M, Guarino F.

Int J Environ Res Public Health. 2016 Jan 6;13(1). pii: E108. doi: 10.3390/ijerph13010108.

49.

Effect of continuous smoking reduction and abstinence on blood pressure and heart rate in smokers switching to electronic cigarettes.

Farsalinos K, Cibella F, Caponnetto P, Campagna D, Morjaria JB, Battaglia E, Caruso M, Russo C, Polosa R.

Intern Emerg Med. 2016 Feb;11(1):85-94. doi: 10.1007/s11739-015-1361-y. Epub 2016 Jan 9.

50.

Evaluation of Post Cessation Weight Gain in a 1-Year Randomized Smoking Cessation Trial of Electronic Cigarettes.

Russo C, Cibella F, Caponnetto P, Campagna D, Maglia M, Frazzetto E, Mondati E, Caruso M, Polosa R.

Sci Rep. 2016 Jan 5;6:18763. doi: 10.1038/srep18763.

Supplemental Content

Loading ...
Support Center